Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
IBM News, April 20th, 2023
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines; Agreement with IBM includes investments in generative AI to improve product design
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM announced an agreement under which Moderna will explore next generation technologies including quantum computing and artificial intelligence to advance and accelerate mRNA research and science.
'Since our inception, we have always strived to be at the forefront of cutting-edge technology, leveraging innovations to deliver the greatest possible impact to people through mRNA medicines,' said Stephane Bancel, Chief Executive Officer of Moderna